Concentrics Research   Report issue

For profit Phase 3 Phase 4
Founded: Indianapolis IN United States (1985)

Organization Overview

First Clinical Trial
2007
NCT00857935
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Concentrics Central Medical Operations Group | Concentrics Research | Concentrics Research LLC | Concentrics Research - STATKING JV

Active Ingredients

Drugs in Phase 4 Trials (1)

spinosad (natroba) (6 trials)

Drugs in Phase 3 Trials (2)

permethrin (nix) (3 trials)

rosuvastatin (crestor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lice Infestations (Phase 3)

Parasitic Diseases (Phase 3)

Scabies (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 3